ライフサイエンスコーパス: HLA typing

1 riation that is undetected with conventional HLA typing.

2 long term in the freezer for low-resolution HLA typing.

3 selection of donors based on high-resolution HLA typing.

4 mplicated as the source of microchimerism by HLA typing.

5 against adalimumab (AAA) levels and class II HLA typing.

6 in the accuracy and time required to perform HLA typing and crossmatching, however, have led us to re

7 PCR HLA typing and mixed leukocyte reaction (MLR) between re

8 HLA typing and the time a patient has spent on the waiti

9 Advancements in human leukocyte antigen (HLA) typing and supportive care have improved the risk-b

10 arly angiograms, donor:recipient serological HLA typing, and biopsy data were reviewed.

11 r, recipient and donor age, duct management, HLA typing, and transplantation year.

12 ermining the allelic state of the HLA genes (HLA typing) as a by-product of standard whole-genome seq

13 HLA typing assignments reported by laboratories are used

14 generally considers intermediate resolution HLA typing at A and B and allele-level typing at DRB1.

15 y-three patients with SCA underwent complete HLA typing at both HLA class I (HLA-A, B) and HLA class

16 All donor-recipient pairs had allele-level HLA typing at HLA-A, -B, -C, and -DRB1, which is the cur

17 Human leukocyte antigen (HLA) typing at the allelic level can in theory be achiev

18 Comparison of the results of HLA typing between the SCA patients with a positive and

19 prove as more laboratories adopt methods for HLA typing by DNA typing techniques.

20 iver low-cost, high-throughput, and accurate HLA typing by multiplexing thousands of samples in a sin

21 Fourteen percent of 12,419 HLA typing comparisons were discrepant in at least one H

22 HLA typing confirmed that the HLA-DR3/DQ2 haplotype is c

23 enile DM, and the results were compared with HLA typing data from 193 patients with adult DM and 797

24 se is desirable to judge the adequacy of the HLA typing data upon which the allocation program is bas

25 is of 412 consecutive adult recipients where HLA typing data was available.

26 onors were categorized by analysis of family HLA-typing data.

27 or acquisition, storage, and manipulation of HLA-typing data; and 4) the development of alternative h

28 c HLA typing showed a "blank," DNA molecular HLA typing detected a HLA-A*0118N allele.

29 Use of 4-digit comprehensive HLA typing enabled great precision, and a large cohort a

30 We obtained olfactory fingerprints and HLA typing for 130 individuals, and found that olfactory

31 HLA typing for 5 loci (A, B, C, DRB1, and DQB1) was unde

32 ymerase chain reaction-based high-resolution HLA typing for class I and class II loci was accomplishe

33 er patient selection, use of high-resolution HLA typing for donor selection, and improved supportive

34 mately 9000 SNPs in the MHC; (ii) four-digit HLA typing for eight Class I and Class II loci, in 96 so

35 s relies on antigen-level (lower resolution) HLA typing for HLA-A and HLA-B, and allele-level for HLA

36 HLA typing for HLA-B27, HLA-B60, and HLA-DR1 was perform

37 g diseases of mucous membranes, we performed HLA-typing for the class II MHC gene DQB1*0301 allele us

38 row Donor Program/Be The Match has collected HLA typing from CLL patients in need of allogeneic hemat

39 Phase 2 studies have documented advances in HLA typing, GVHD prophylaxis, and infection prevention,

40 ditioning regimen, and with available allele HLA typing (HLA-A, -B, -C, and -DRB1).

41 cted controls from North India and follow-up HLA typing in 355 cases and 441 controls from Gujarat.

42 association testing in 202 family trios and HLA typing in 94 case patients and 94 controls.

43 Analysis of HLA typing in patients with Fabry's disease may further

44 pite the success of human leukocyte antigen (HLA) typing in allogeneic stem cell transplantation (SCT

45 us population were studied by sequence-based HLA typing, in which frequencies of the HLA-B and HLA-C

46 positive for HLA DQB1*0602, we suggest that HLA typing is a useful screen before lumbar puncture.

47 Because HLA typing is not routine in corneal transplantation, a

48 HLA typing may prove useful in identifying SCA patients

49 related matched donors awaits improvement in HLA-typing methodology.

50 However, classical HLA typing methods are often prohibitively expensive for

51 Currently, HLA typing methods are relatively expensive and time con

52 and the development of precise and efficient HLA typing methods using DNA technology.

53 and the development of precise and efficient HLA typing methods using DNA technology.

54 Molecular-based HLA-typing methods were used to test the association of

55 Rapid methods of DNA-based HLA typing now makes it feasible to utilize this methodo

56 Molecular techniques were used for HLA typing of 219 white patients with systemic lupus ery

57 HLA typing of mothers and sons indicated that HLA compat

58 in the proband, mapping of the TNX gene and HLA typing of this family suggest recessive inheritance

59 arrying out ABO and human leukocyte antigen (HLA) typing of the thawed units before transplantation.

60 he first known experience of preimplantation HLA typing performed without PGD for a causative gene, p

61 labeling errors, the rapid serologic class I HLA typing procedure was done on thawed units just befor

62 The Working Group defined terms for HLA typing resolution, HLA matching, and a format for re

63 HLA typing revealed a dramatic association between the H

64 HLA typing revealed that 155 relatives carried this prot

65 typing of prospective donors, in addition to HLA typing, should be performed to identify HLA-matched

66 Although serologic HLA typing showed a "blank," DNA molecular HLA typing de

67 HLA typing showed the alleles HLA-DRB1*0701 (odds ratio,

68 Our current protocol calls for HLA typing to eliminate parents who are homozygous at al

69 ) implementation of human leukocyte antigen (HLA) typing using Polysolver or HLAminer combined with c

70 DNA-based HLA typing was conducted in 67 proband-mother pairs and

71 rican cohort, molecular class I and class II HLA typing was done on 31 subjects with persistent HBV i

72 antigen or allele, high-resolution class II HLA typing was done retrospectively.

73 HLA typing was done with molecular techniques with a min

74 nvestigational therapies were discussed, and HLA typing was initiated.

75 HLA typing was performed for 449 participants.

76 Sequence-based HLA typing was performed for all 110 participants who in

77 HLA typing was performed in 4 patients, all of whom carr

78 ethnically varied cohort, molecular class II HLA typing was performed on 200 HCV clearance and 374 ma

79 HLA typing was performed on 553 (80%) of the 689 enrolle

80 HLA typing was performed using serologic techniques.

81 HLA typing was performed using standard complement-depen

82 A HLA-typing was performed in all patients.

83 tic neoepitope analysis and patient-specific HLA typing, we identified candidate tumor neoantigens fo

84 four patients who had siblings available for HLA typing were actively screened for enrollment, and 15

85 rected count increments (CCIs) and molecular HLA typing were available for 523 transfusions.

86 TNFalpha and IL-1 cytokine polymorphism and HLA typing were performed in 221 Caucasian patients with

87 Endomysial antibodies and HLA typing were routinely available in only half of the

88 toantibody studies, serological studies, and HLA typing were undertaken.

89 HLA typing with NGS should prove useful to select partic

90 tested healthy donors irrespective of their HLA typing, with a mean frequency of 0.29 cells per mill